Novo Nordisk Sues Eli Lilly Over Drug Ads | Raleigh News

Novo Nordisk is suing Eli Lilly over misleading weight-loss drug ads, accusing them of cherry-picking old studies to make Mounjaro and Zepbound look superior—while ignoring higher doses of their own drugs. Both giants are locked in a fierce market battle, with Eli Lilly rising and Novo Nordisk slipping, even cutting jobs. The lawsuit highlights how Lilly’s ads omitted key comparisons, sparking a high-stakes legal showdown over who controls the narrative in the booming GLP-1 drug race. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/2df367cc951df0e2